World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
92
Citations
31434
World Ranking
2211
National Ranking
145

Overview

Simon L. Croft is affiliated with the London School of Hygiene & Tropical Medicine in the United Kingdom. Their research primarily lies in the field of Medicine, with a particular focus on Public Health, Environmental and Occupational Health, Epidemiology, Organic Chemistry, Immunology, and Insect Science.

The scientist's main research areas encompass studies on Leishmaniasis, Trypanosoma species, synthesis and biological evaluation of compounds, toxin mechanisms and immunotoxins, insect and pesticide research, coagulation-related topics, and bioactive compounds with antitumor properties.

Frequent co-authors collaborating with Simon L. Croft include Katrien Van Bocxlaer, Vanessa Yardley, Andy Harris, Alaa Riezk, and Sudaxshina Murdan.

Simon L. Croft has contributed to research published in various scientific venues with multiple publications in specialized journals. The predominant publication venues are:

  • PLoS Neglected Tropical Diseases
  • Molecules
  • Seminars in Immunopathology
  • Natural Product Reports
  • Pharmaceutics

Notable recent papers authored or co-authored by Simon L. Croft include:

  • "Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugs" (2020, Seminars in Immunopathology)
  • "Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis" (2020, Molecules)
  • "Marine alkaloids as bioactive agents against protozoal neglected tropical diseases and malaria" (2021, Natural Product Reports)
  • "Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis" (2021, Pharmaceutics)
  • "Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs" (2020, Microorganisms)

Best Publications

  • Drug Resistance in Leishmaniasis

    Simon L. Croft;Shyam Sundar;Alan H. Fairlamb

  • Antimalarial drug discovery: efficacy models for compound screening

    David A. Fidock;Philip J. Rosenthal;Simon L. Croft;Reto Brun

  • Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs

    Simon L. Croft;Graham H. Coombs

  • Visceral leishmaniasis : current status of control, diagnosis, and treatment, and a proposed research and development agenda

    Philippe J Guerin;Philippe J Guerin;Piero Olliaro;Piero Olliaro;Shyam Sundar;Marleen Boelaert

  • Kinetoplastids: related protozoan pathogens, different diseases

    Ken Stuart;Reto Brun;Simon Croft;Alan Fairlamb

  • Current scenario of drug development for leishmaniasis.

    Simon L Croft;Karin Seifert;Vanessa Yardley

  • Chemotherapy of Leishmaniasis

    Simon L Croft;Vanessa Yardley

  • Chemotherapy of trypanosomiases and leishmaniasis

    Simon L. Croft;Michael P. Barrett;Julio A. Urbina

  • Natural products as antiparasitic drugs.

    O. Kayser;A. F. Kiderlen;S. L. Croft

  • Leishmaniasis chemotherapy—challenges and opportunities

    S.L. Croft;P. Olliaro;P. Olliaro

  • Leishmaniasis: new approaches to disease control

    Clive R Davies;Paul Kaye;Simon L Croft;Shyam Sundar

  • Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.

    Michael B. Martin;Joshua S. Grimley;Jared C. Lewis;Huel T. Heath

  • Management of trypanosomiasis and leishmaniasis

    Michael P. Barrett;Simon L. Croft

  • Chemotherapy in the Treatment and Control of Leishmaniasis

    Jorge Alvar;Simon Croft;Piero Olliaro

  • Structure-activity relationships of antileishmanial and antimalarial chalcones.

    Mei Liu;Prapon Wilairat;Simon L Croft;Agnes Lay-Choo Tan

  • 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.

    L Salmon-Chemin;E Buisine;Yardley;S Kohler

  • Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class†

    Richard K. Haynes;Burkhard Fugmann;Jörg Stetter;Karl Rieckmann

  • The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani.

    S.L. Croft;R.A. Neal;W. Pendergast;J.H. Chan

  • Formulation of amphotericin B as nanosuspension for oral administration.

    O Kayser;C Olbrich;V Yardley;A F Kiderlen

  • An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani

    R. A. Neal;S. L. Croft

Frequent Co-Authors

Vanessa Yardley
Vanessa Yardley London School of Hygiene & Tropical Medicine
Alan H. Fairlamb
Alan H. Fairlamb University of Dundee
Julio A. Urbina
Julio A. Urbina Instituto Venezolano de Investigaciones Científicas
Ian H. Gilbert
Ian H. Gilbert University of Dundee
Shyam Sundar
Shyam Sundar Banaras Hindu University
Richard B. Sessions
Richard B. Sessions University of Bristol
Oliver Kayser
Oliver Kayser TU Dortmund University
Reto Brun
Reto Brun University of Basel
Paul M. Kaye
Paul M. Kaye Hull York Medical School
Eric Oldfield
Eric Oldfield University of Illinois at Urbana-Champaign

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Simon L. Croft

Trending Scientists

Recently Published Articles